NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 9 மணி நேரத்திற்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Vidhi Specialty Food Submits Q2 FY27 Results; Independent Director Resigns
Vidhi Specialty Food Ingredients reported that its Board approved the un-audited Standalone and Consolidated financial results for Q2 and H1 ended September 30, 2026. The filing includes the cash flow statement showing net cash inflow from operating activities of ₹2,683.16 lakhs for the half-year (down from ₹4,478.57 lakhs in the prior year period). In addition, Independent Director Mr. Ashit K. Doshi resigned with effect from October 26, 2026, citing personal reasons. The update was re-submitted as a readable copy to the stock exchanges.
உச்சம் நம்பிக்கை
என்ன மாறியதுRe-filing of readable Q2 FY27 financial results and formal intimation of the resignation of Independent Director Ashit K. Doshi.
ஏன் இது முக்கியம்Cash generation from operations declined year-on-year in H1, while fixed capital expenditure moderated compared to the previous fiscal year.
H1 Operating Cash Inflow: ₹2,683.16 லட்சம்H1 Purchase of Fixed Assets: ₹261.80 லட்சம்H1 Net Outflow from Investing Activities: ₹2,504.69 லட்சம்Closing Cash & Cash Equivalents: ₹805.99 லட்சம்
📅 குறுகிய காலம்Routine compliance filing of quarterly accounts; minimal short-term stock price impact expected.
📈 நீண்ட காலம்Limited; structural trajectory depends on the ramp-up of Dahej and Roha Phase II capacities as highlighted in earlier strategy updates.
⚠ அபாய எச்சரிக்கைகள்
Operating cash flow reduced during H1 compared to the previous year
Vacancy on Audit and Nomination & Remuneration Committees due to director resignation
👀 கவனிக்க வேண்டியவை
Track the full quarterly P&L performance for Q2 FY27 once details are fully analysed, and watch for board committee reconstitution following the Independent Director's departure.
Vidhi Specialty Plans ₹75-85 Cr Dahej Expansion, Targets Full Dahej Utilization in FY27
Vidhi Specialty Food Ingredients shared its Q2 & H1 FY27 earnings call transcript, highlighting that its existing Dahej facility is on track to achieve full capacity utilization in the current financial year. The company announced a planned capital expenditure of ₹75 to ₹85 crore on a newly allotted 16,834 sq meter plot in Dahej GIDC, with construction starting in Q4 FY27 and commissioning targeted around mid-to-end FY28. This planned capex represents ~18% of TTM revenue (₹438 crore) and ~24% of net worth (₹329 crore). Concurrently, the company is advancing pharma-grade tablet coating brand CoatIcon with dedicated capex at its Arjun subsidiary in Roha, amid longer vendor qualification cycles of 6-12 months.
உச்சம் நம்பிக்கை
என்ன மாறியதுFiling of the Q2 & H1 FY27 earnings conference call transcript outlining capex guidance, timeline, and expansion roadmaps.
ஏன் இது முக்கியம்The ₹75-85 crore capex will add high-margin forward integrated capacity, supporting long-term growth as the current Dahej facility reaches full utilization in FY27.
Planned Dahej Capex: INR75 crores to INR85 croresCapex vs Net Worth: ~24.3%Capex vs TTM Revenue: ~18.3%New Dahej Plot Area: 16,834 square metersH1 FY27 Working Capital Outflow: INR14.7 கோடி
📅 குறுகிய காலம்Transcript reflects operational ramp-up and margin-supportive product mix shifts, though working capital requirements increased during H1 FY27.
📈 நீண்ட காலம்Commissioning of the new Dahej unit by mid-to-late FY28 and commercialization of CoatIcon tablet coatings position the company for margin expansion into high-value specialty formulations.
⚠ அபாய எச்சரிக்கைகள்
Lengthy 6-12 month pharma qualification cycles for CoatIcon
Increased working capital requirements due to input cost inflation and inventory
👀 கவனிக்க வேண்டியவை
Track the groundbreaking of the ₹75-85 crore Dahej expansion in Q4 FY27 and the pace of pharma vendor approvals for the CoatIcon portfolio.
Vidhi Specialty Reports Q2 FY27 Revenue Up 82% YoY to ₹136.5 Cr; PAT Up 66.9% to ₹17.6 Cr
Vidhi Specialty Food Ingredients reported a strong set of consolidated numbers in its Q2 FY27 presentation, with revenue from operations surging 82% YoY to ₹136.5 crore compared to ₹75.0 crore in Q2 FY26. EBITDA rose 49.2% YoY to ₹26.4 crore, while Profit After Tax expanded 66.9% YoY to ₹17.6 crore. For H1 FY27, revenue reached ₹282.8 crore (up 73.6% YoY) and PAT reached ₹34.7 crore (up 49.3% YoY). The growth was primarily driven by manufacturing sales reaching ₹108.6 crore in Q2 FY27 and rising demand across value-added products.
உச்சம் நம்பிக்கை
என்ன மாறியதுVidhi Specialty published its Q2 and H1 FY27 investor presentation, showcasing significant revenue and profit growth alongside business updates on tablet coatings expansion.
ஏன் இது முக்கியம்Demonstrates robust volume growth and capacity utilization from the Dahej SEZ operations, although margin dilution occurred YoY due to changing product and sales mix.
📅 குறுகிய காலம்The strong YoY top-line and bottom-line expansion should be received favorably by the market, though sequential moderation in revenue (-6.7% QoQ) will be noted.
📈 நீண்ட காலம்Strategic diversification into tablet coatings ('Coat Icon') and value-added color products aims to elevate the mix of >50% gross margin items, supporting sustainable long-term ROCE.
⚠ அபாய எச்சரிக்கைகள்
Gross margin contraction from 50.8% in Q2 FY26 to 38.2% in Q2 FY27
Working capital intensity with trade receivables rising to ₹170.8 Cr as of September 2026
👀 கவனிக்க வேண்டியவை
Track the margin trajectory in upcoming quarters to monitor whether gross margins (38.2% in Q2 FY27 vs 50.8% in Q2 FY26) recover as high-margin specialty offerings and the tablet coatings business ramp up.
66% Revenue Growth in Q1 FY27; Pilot Plants Ready for 500 MT/Month Expansion
Vidhi Specialty Food Ingredients reported a strong Q1 FY27 with revenue surging 66.4% YoY to ₹146.3 Cr, driven by robust demand and a strategic shift toward specialty products. While EBITDA margins compressed YoY to 17.8% (from 23.4%), they showed sequential improvement from 16.8% in Q4 FY26. The company is advancing two major expansion projects totaling 500 MT/month capacity, with pilot plants already operational. Management aims to pivot the revenue mix from 15% to 50% in favor of high-margin value-added products.
உச்சம் நம்பிக்கை
என்ன மாறியதுSignificant YoY revenue jump and progress update on two major expansion projects with pilot plants now ready for sampling.
ஏன் இது முக்கியம்The company is transitioning from a commodity-focused food color player to a high-margin specialty solutions provider, which could structurally improve long-term profitability and market positioning.
📅 குறுகிய காலம்Positive sentiment expected due to sharp top-line growth and sequential margin recovery.
📈 நீண்ட காலம்Structural growth potential is high if the company successfully scales the 500 MT/month capacity and achieves its 50% specialty product mix target.
👀 கவனிக்க வேண்டியவை
Monitor the commercialization timeline of the 500 MT/month expansion projects and the stabilization of EBITDA margins as the product mix shifts toward specialty ingredients.
Vidhi Specialty Food Ingredients Approves Q1 FY27 Results; AGM Set for Sept 24, 2026
Vidhi Specialty Food Ingredients' Board met on July 29, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company has also scheduled its 33rd Annual General Meeting (AGM) for September 24, 2026. This follows a fiscal year (FY26) where the company achieved a revenue of ‡380 Cr and a PAT of ‡49 Cr. The meeting concluded within one hour, and the statutory auditors' Limited Review Report was taken on record.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has completed its internal and auditor review of the first quarter's financial performance and formalized the date for its annual shareholder meeting.
ஏன் இது முக்கியம்Quarterly results are critical to track the company's 28.3% expected growth rate and its strategic shift from low-margin trading to high-margin specialty food ingredients.
📅 குறுகிய காலம்The stock may react to the specific Q1 growth and margin figures compared to the previous quarter's ‡123 Cr revenue.
📈 நீண்ட காலம்Structural growth depends on the commercialization of new R&D products with >50% gross margins and the Roha Phase II facility expansion.
👀 கவனிக்க வேண்டியவை
Investors should examine the detailed Q1 FY27 results to verify if the company is successfully increasing its share of high-margin products (target 50% of revenue) and leveraging the Dahej plant capacity.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Vidhi Specialty Food Ingredients FY26 Net Profit Rises 10.8% to ‡49.15 Cr; Plans ‡80 Cr+ Capex
Vidhi Specialty Food Ingredients reported a resilient FY26 with a net profit of ‡49.15 crores, a 10.8% YoY increase despite a slight revenue dip to ‡380 crores. EBITDA margins improved significantly to 20.52% from 17.91%, driven by a better product mix and manufacturing efficiencies. The company is aggressively expanding into the pharmaceutical coating segment with its 'CoatIcon' range and has announced a Phase 1 capex of ‡75-85 crores for new products. Management expects full capacity utilization in FY27 and commissioning of new projects within 18 months.
முக்கிய அம்சங்கள்
FY26 EBITDA grew to ‡78 crores from ‡68 crores, with margins expanding to 20.52%.Net profit increased by 10.80% YoY to ‡49.15 crores despite global economic headwinds and tariff pressures.Planned capex of ‡75-85 crores for new specialty products and ‡5-12 crores for the CoatIcon pharma range.Debt-to-equity ratio remains very low at 0.28%, with ROCE improving to 20.90%.Management expects full utilization of both Dahej and Roha facilities in the current financial year (FY27).
👀 கவனிக்க வேண்டியவை
Investors should monitor the progress of the 'CoatIcon' sampling and the execution of the ‡80 crore+ capex, which signals a strategic shift towards higher-margin specialty segments. The strong balance sheet and margin expansion provide a solid foundation for long-term growth.
Vidhi Specialty Food Ingredients FY26 PAT Grows 13% to ₹49 Cr; Major Capacity Expansion Underway
Vidhi Specialty Food Ingredients reported a resilient FY26 with Profit After Tax (PAT) increasing 13% to ₹49.0 Cr, despite a marginal 0.6% decline in annual revenue to ₹380.0 Cr. The company is successfully transitioning from low-margin trading to high-margin manufacturing, which led to EBITDA margins expanding to 20.5% in FY26 from 17.9% in FY25. Management has opted to skip the final dividend to reinvest capital into significant capacity expansions at Roha and Dahej, targeting the pharmaceutical and cosmetic sectors. Q4 FY26 showed strong momentum with revenue growing 12% YoY to ₹122.7 Cr.
முக்கிய அம்சங்கள்
FY26 PAT rose 13% to ₹49.0 Cr and EBITDA increased 14% to ₹78.0 Cr despite flat revenue growth.EBITDA margins improved to 20.5% for the full year, driven by a better product mix and manufacturing focus.Q4 FY26 revenue stood at ₹122.7 Cr, a 12% YoY increase, with PAT for the quarter up 10.5% to ₹13.1 Cr.Successfully operationalized Dahej SEZ Phase-I (350 TPM), with two more projects (500 MT total capacity) in the pilot/sampling stage.Maintained a strong balance sheet with a healthy Debt-to-Equity ratio of 0.20 as of March 2026.
👀 கவனிக்க வேண்டியவை
Investors should view the margin expansion and the shift toward specialty products like tablet coatings as a positive long-term catalyst. The stock warrants a 'Watch' for the successful execution and ramp-up of the new Roha and Dahej facilities which are expected to drive the next leg of growth.
Vidhi Specialty Food Ingredients Limited has approved its audited standalone and consolidated financial results for the quarter and full year ended March 31, 2026. The company confirmed that its statutory auditors, Bhuta Shah & Co LLP, issued an audit report with an unmodified opinion, ensuring the reliability of the financial statements. The filing includes the formal statement of assets, liabilities, and cash flows for the fiscal year. This board meeting outcome serves as the final verified reporting for the 2025-26 financial period.
முக்கிய அம்சங்கள்
Approved audited standalone and consolidated financial statements for the year ended March 31, 2026Statutory auditors Bhuta Shah & Co LLP issued an audit report with an unmodified opinionBoard meeting concluded within one hour, held on May 14, 2026, from 11:30 a.m. to 12:30 p.m.Submission includes full-year Statement of Assets and Liabilities and Cash Flow Statement
👀 கவனிக்க வேண்டியவை
Investors should review the detailed financial tables in the full report to assess year-on-year growth in revenue and profitability. The unmodified audit opinion is a positive indicator of financial transparency and reporting standards.
Vidhi Specialty 9M FY26 PAT Rises 13.6% to ₹35.8 Cr; EBITDA Margins Expand to 22.3%
Vidhi Specialty Food Ingredients reported a resilient performance for 9M FY26, with PAT growing 13.6% YoY to ₹35.8 crore despite a 5.7% decline in revenue to ₹257.3 crore. The company is successfully transitioning its business model from low-margin trading to high-margin manufacturing, which led to a significant EBITDA margin expansion from 17.7% to 22.3%. Capacity expansion is a key growth driver, with the Dahej plant (350 MT) now operational and the Roha Phase II expansion (350 MT) on track to reach a total capacity of 1,000 TPM by 2025-26. Financial health remains robust with a low debt-to-equity ratio of 0.20.
முக்கிய அம்சங்கள்
9M FY26 EBITDA increased by 18.8% YoY to ₹57.4 crore with margins improving by 460 bps to 22.3%.Phase I Dahej SEZ plant (350 MT) successfully commenced production, increasing total capacity to 675 TPM.Phase II Roha expansion (350 MT) is in progress with an expected completion timeline of 2025-26.9M FY26 PAT stood at ₹35.8 crore, up 13.6% YoY, although Q3 FY26 PAT saw a minor 2.5% dip due to lower exchange gains.Maintains a strong balance sheet with a healthy Debt-to-Equity ratio of 0.20.
👀 கவனிக்க வேண்டியவை
Investors should monitor the utilization levels of the new Dahej facility and the progress of the Roha Phase II expansion. The structural shift toward higher-margin manufactured products makes the company a strong candidate for long-term growth in the specialty chemicals space.
Vidhi Specialty Food Ingredients approved its un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The board meeting, held on February 02, 2026, also reviewed the Limited Review Report for the same period. A significant update for shareholders is the board's decision to skip the declaration of a third interim dividend for the 2025-26 fiscal year. Investors should now look for the detailed profit and loss statements to evaluate operational performance.
முக்கிய அம்சங்கள்
Approval of un-audited standalone and consolidated financial results for the quarter ended December 31, 2025.Board of Directors officially decided not to declare a 3rd interim dividend for the financial year 2025-26.Limited Review Reports for the nine-month period were taken on record by the board.The board meeting was conducted and concluded within a one-hour timeframe on February 02, 2026.
👀 கவனிக்க வேண்டியவை
Investors should examine the detailed financial tables to assess revenue and margin trends. The decision to skip the third interim dividend suggests the company may be prioritizing cash conservation for capital expenditure or debt management.
Vidhi Specialty Q2 Net Profit Rises to ₹10.56 Cr; Declares ₹1.50 Interim Dividend
Vidhi Specialty Food Ingredients reported a consolidated net profit of ₹10.56 crore for Q2 FY26, a slight increase from ₹10.32 crore in the same quarter last year, despite a 17.8% decline in revenue to ₹74.99 crore. For the first half of FY26, the company showed stronger performance with net profit rising 23.9% YoY to ₹23.26 crore. A significant highlight is the declaration of a second interim dividend of ₹1.50 per share (150% of face value). The company managed to maintain profitability through effective cost control even as the top line faced pressure.
முக்கிய அம்சங்கள்
Consolidated Net Profit for Q2 FY26 stood at ₹10.56 crore, up from ₹10.32 crore YoY.Revenue from operations for the quarter decreased to ₹74.99 crore compared to ₹91.29 crore in Q2 FY25.Declared a second interim dividend of ₹1.50 per equity share for the financial year 2025-26.H1 FY26 consolidated net profit grew significantly to ₹23.26 crore from ₹18.77 crore YoY.The record date for the interim dividend is fixed as Thursday, November 13, 2025.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's improved margins and consistent dividend payout despite the revenue dip. The stock remains a hold for those seeking steady income through dividends, but monitoring future revenue growth is essential.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
